Impaired cognitive function and structural changes in cerebral white matter after chemotherapy;Strukturelle Veränderungen der weien Hirnsubstanz durch Chemotherapie und ihre Korrelation mit kognitiven Beeinträchtigungen : Die internistisch-onkologische Sicht

Strahlentherapie und Onkologie

Volumn 188, Issue 6, 2012, Pages 525-526

  Wilhelm, M ^a  

^a KLINIKUM NÜRNBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CLINICAL ASSESSMENT; COGNITIVE DEFECT; LONGITUDINAL STUDY; NOTE; WHITE MATTER;

EID: 84862649028     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0111-6     Document Type: Note

References (4)

1. Irwin MR, Cole SW (2011) Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol 11:625-632
2. McDonald B, Conroy S, Ahles T et al (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 123:819-828
3. Schagen SB, Vardy J (2007) Steering committee of the international cognition and cancer task force: cognitive dysfunction in people with cancer. Lancet Oncol 8:852-853
4. Syrjala KL, Dikmen S, Langer SL et al (2004) Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood 104:3386-3392 (Pubitemid 39507163)